コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ming growth factor beta receptor type II, or prolactin receptor).
2 er retrovirus encoding the non-hematopoietic prolactin receptor.
3 , indicating transport is independent of the prolactin receptor.
4 binding domain in a fashion analogous to the prolactin receptor.
5 ot only the ER but also the progesterone and prolactin receptors.
6 lymphocytes, and both B and T cells express prolactin receptors.
7 several candidate genes (cyclin D1, Stat5A, prolactin receptor) abrogates normal mammary gland devel
8 location of STAT5 can be used as a marker of prolactin receptor activation in hypothalamic dopaminerg
9 that Stat5a and Stat5b respond similarly to prolactin receptor activation, but also suggested that t
10 zed acini, allowing both the exposure of the prolactin receptor and sustained activation of STAT5.
11 f matrices also increased co-localization of prolactin receptors and integrin-activated FAK, implicat
12 termini of the long (LF) or short (SF) human prolactin receptors and luciferase/GFP such that biolumi
15 in mice have established a critical role for prolactin receptors and transcription factor Stat5 in ma
16 o the molecular mechanisms involved in human prolactin receptor antagonist (hPRL-G129R)-induced apopt
18 dues necessary for functional binding to the prolactin receptor are clustered on the prolactin surfac
20 d surface plasmon resonance to measure human prolactin receptor binding kinetics and stoichiometries
21 hese data support an "induced-fit" model for prolactin receptor binding where binding of the first re
22 xpress the short 1b form (SF1b) of the human prolactin receptor, but DU145 and PC3 cells express only
23 olecular architecture of the monomeric human prolactin receptor by combining experimental and computa
24 erated against hPRL and the ECD of the human prolactin receptor, co-immunoprecipitation analyses of h
25 e brain in PRLR(-/-) mice lacking functional prolactin receptors compared to control mice, indicating
26 acts to promote Stat5 activation by the JAK2.prolactin receptor complex, while negatively modulating
27 sis was that prolactin induced activation of prolactin receptor coupled signaling leads to increased
28 sion of angiotensin-vasopressin receptor and prolactin receptor, decreased 5 alpha-reductase, and mix
31 tion factor results in increased steroid and prolactin receptor expression concomitant with a 10-fold
32 concomitant appearance of a cell-associated prolactin receptor fragment containing the extracellular
36 hat promoter III is of central importance in prolactin receptor gene transcription across species.
37 t were due to a heterozygous mutation in the prolactin receptor gene, PRLR, resulting in an amino aci
38 nscriptional activation of promoter I of the prolactin receptor gene, which may explain the tissue-sp
40 binds the extracellular domain of the human prolactin receptor (hPRLbp) using surface plasmon resona
42 have identified a novel exon 11 of the human prolactin receptor (hPRLR) gene that is distinct from it
44 To determine why, we explored the human PRL-prolactin receptor (hPRLR)-Janus kinase 2 (JAK2)-signal
48 the expression of the long form of the human prolactin receptor in fetal, prepubertal, and adult pros
50 at signal transduction mechanisms coupled to prolactin receptors in hypothalamic dopaminergic neurons
52 is the first indication of a role for short prolactin receptors in the regulation of cell proliferat
54 is study, we have analyzed the expression of prolactin receptors, including the long receptor form (L
55 uclear translocation of STAT5 as a marker of prolactin receptor induced signaling and expression of F
58 to assess the extent to which the absence of prolactin receptor is limiting, under systemic condition
62 esult from systemic endocrine alterations in prolactin receptor knockout mice, mammary epithelium fro
64 eptor knockout mice, mammary epithelium from prolactin receptor knockouts was transplanted into mamma
65 tion was associated with reductions in islet prolactin receptor levels, STAT5 nuclear localization an
71 investigate whether increased expression of prolactin receptor (PRL-R) during lactation is caused by
72 l mutation that uncouples signaling from the prolactin receptor (PRL-R) to its downstream mediator St
74 in and placental lactogen signal through the prolactin receptor (PRLR) and contribute to adaptive bet
75 ), is significantly reduced due to decreased prolactin receptor (Prlr) and ErbB4 expression in Xbp1-d
76 comes by activating their cognate receptors, prolactin receptor (PrlR) and erythropoietin receptor (E
77 show that CN/Nfatc1 regulates expression of prolactin receptor (Prlr) and that canonical activation
78 e examined the specific contributions of the prolactin receptor (PrlR) and the signal transducers and
79 cently showed that a retrovirally transduced prolactin receptor (PrlR) efficiently supports the diffe
81 induce the oncogenic activation of the human prolactin receptor (PRLR) was examined by deleting 178 a
82 led that >98% of ovarian cancers express the prolactin receptor (PRLR), forming the basis of a new mo
87 n neuroblastoma SH-SY5Y cells, we employed a prolactin receptor (PrlR)/erythropoietin receptor (EpoR)
91 ng through hepatocyte-predominant short-form prolactin receptors (PRLR-S), constrained TNF receptor-a
93 istribution and ontogenesis of expression of prolactin receptors (PRLRs) in human fetal tissues at 7.
94 igh-affinity ligand-binding interface of the prolactin receptor, resulting in a loss of downstream si
95 rolactin, a lactogenic hormone, binds to two prolactin receptors sequentially, the first receptor bin
96 d OAS expression may result in modulation of prolactin receptor signaling and thus contribute to supp
97 correlated with the luteal induction of the prolactin receptor signaling inhibitors suppressor of cy
99 st cancer progression and therapy as loss of prolactin receptor-Stat5 signaling occurs frequently and
100 Members of the cytokine/growth hormone (GH)/prolactin receptor superfamily transduce signals by asso
102 h impaired intercellular junction formation, prolactin receptor trafficking, and alveolar lumen devel
103 Quantification of differential expression of prolactin receptor variants by real-time PCR in 15 pairs
106 Using a novel conditional deletion of the prolactin receptor, we have identified functional subpop
107 tinal polypeptide, purinergic, androgen, and prolactin receptors were also expressed in gland of Wolf
109 in barrier, was examined for the presence of prolactin receptors, which would render it a potential s
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。